Portable medical devices have revolutionized the way in which physicians monitor and determine a patient’s health. Smart glucose monitoring devices are being used to measure the glucose levels in a patient’s blood on the go. These smart devices can be connected to a Smartphone in order to monitor sugar levels and take necessary actions quickly. In addition, latest automated insulin pumps have been developed to continuously monitor glucose levels and adjust insulin levels with no or little input from the user.
A rising number of people with lower-limb disorders are bolstering the need or mobility aid and assistive medical devices across the world. The growing morbidity and health burden of complications such as cerebral embolisms and spinal cord injuries are driving the demand for the medical exoskeleton. Advanced exoskeletons are being developed to enable people with paraplegia, amputees, and stroke and spinal cord injury sufferers to get back on their feet sooner. Such advancements in instrumentation and video imaging are allowing physicians to renovate several procedures in various surgical specialties starting from open to endoscopic surgeries.
This edition of MedTech Outlook features companies such as KitoTech Medical, a Seattle-based medical device company that has developed microMend, a unique wound closure device that provides safe, secure, and very rapid skin closure for a variety of incisions.
MedTech Outlook’s editorial board has assessed and shortlisted some of the most prominent organizations in the industry that solve challenges by implementing the current technological trends in the space. Through this special edition, we present to you “Top 10 MedTech Devices Startups — 2019.”
Nestled in the heart of Seattle, the team at KitoTech is equipping doctors with microMend® — an innovative next-generation wound closure product. It is designed like a butterfly bandage, but incorporates two arrays of miniature staples that the company calls Microstaples. In contrast to sutures and staples, microMend is straightforward to use and thus achieves consistent results that are independent of surgical skills. The ease of use and rapid application are microMend’s strongest suits. In a clinical study directly comparing microMend to sutures in surgery, 85 percent of doctors and nurses rated microMend superior, while 90 percent of patients rated cosmetic results better with microMend
Avelas Biosciences is a clinical-stage oncology company developing AVB-620, a novel drug-device combination product for use during cancer surgery. AVB-620 helps improve operation by detecting cancer in real-time and has the potential to become part of standard-of-care treatment for a variety of cancer surgeries. AVB-620 has been developed from pioneering technology and is currently in a registration trial for detecting positive margins during breast cancer surgery. Avelas is also willing to investigate the product in a subset of other cancer surgeries, including ovarian, colorectal, head and neck, lung, melanoma, and sarcoma
Nanōmix, founded in 2000, is a famous developer of mobile, affordable point-of-care diagnostics. The company offers a handheld testing platform and assays providing rapid, accurate, quantitative information for use in settings where time-to-diagnosis is critical to clinical decision making and improved patient care. The company is expanding access to quality health care by bringing diagnostics to the point of initial patient interaction, whether in the hospital or pre-hospital, remote, or alternative settings. Nanōmix’s first assay addresses the critical need for faster sepsis diagnosis. It is also developing a deep pipeline of other high-value tests where the rapid availability of high-quality diagnostic information can improve patient outcomes
ONKOS SURGICAL believes that people suffering from cancer requires surgery deserve solutions designed specifically for them. These individuals, their caregivers, and their support network deserve an organization that will passionately champion their cause. The company exists to maintain a singular focus on the surgical oncology by looking at everything they do through the lens of the cancer patient and their surgeon. Built on a digital platform, the solutions of the company are rooted in unmatched expertise of patient imaging analysis, personalized surgical planning, and the latest advancements in 3D printing
Most of the time, sepsis starts with an infection, the body starts to over-react to the severe infection, and it is a medical emergency as it can be life-threatening. Patchd helps this diagnosis occur earlier so that the infections which will develop into sepsis can be detected and managed before they become serious. Patchd Medicals have developed a wearable technology known as patchd to predict and prevent sepsis. The technology works by using a simple device and some complex AI to monitor the patients when they leave the hospitals. Patchd can detect the early signs of sepsis and sent an alert to the physician who can then intervene
Potrero Medical is a predictive health company that is developing the next generation of smart sensors and artificial intelligence. Currently, the company is developing a predictive health platform for smart sensors and AI to help medical teams better predicts adverse outcomes in critical care settings. The organization have made it their mission to improve the clinicians in transforming the way patients are taken care of by developing a predictive technology that will detect a critical illness at an early stage. With technology, it will not only become more accessible for the healthcare provider to take better care of their patients, but they can also predict any critical disease at an early stage
The healthcare providers can now offer their patients a pain-free continuous blood pressure monitor with the flexible sensor of PyrAmes. The company is an early-stage startup building a transformative continuous blood pressure monitoring device in the form of a unique lightweight, wireless, comfortable sensor platform. Their paper-thin flexible sensor and compact wristwatch form factor make an incredible alternative to the arterial lines and inflatable cuff-based blood monitoring systems. The sensor platform can continuously monitor the blood pressure of the patients, and it is also light in weight, making it comfortable to carry
Respirix is the developer of a portable device that is designed to monitor cardiac health. The company offers a portable device that provides proprietary insights into the pulmonary vasculature non-invasively. The device also aims to address both at-home monitoring and critical care applications in categories such as heart failure and hemodynamic. Therefore, the company aims to change the critical cardiac monitoring for critical care, operating rooms, and also heart failure patients who require invasive pulmonary catheters and implants. Respirix have approached their patients with a device that combines a unique physiological signal, off-the-shelf sensors, and cloud computing to predict patient health
Savonix delivers the first scientifically proven, consumer-style app that can be installed in android phones and tablets, providing valuable information about brain health and wellness. Savonix Mobile is an accurate, accessible, and affordable tool for professional cognitive screening. It empowers healthcare providers, payers, and researchers to evaluate and leverage results to improve health and treatment outcomes. Led by clinical neuro-psychologists, neuroscientists, and IT leaders, Savonix sets the global standard on cognition and its relationship to risk, health outcomes, and the development of innovative therapies. Savonix evidence-based tests are digitally validated versions of the gold standard cognition tests, many of which neuropsychologists have used effectively since the 1930s
toSense, founded in 2014, is focused on rapidly bringing devices to the market that address real-world medical issues. toSenseâ offers unique solutions, including both hardware in terms of custom sensors and software as in servers, along with wireless solutions connecting these components. Their core focus is the CoVa Sensor and its unique hardware and algorithms. It can be used for different applications ranging from remote patient monitoring, post-discharge monitoring, and clinic monitoring. Third-party software systems can integrate with this novel component utilizing the company’s gateways and web services.
Check This Out: